Intercept Pharmaceuticals

1 follower

‌

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Kathleen Munster
Chief Quality Officer & SVP, Technical Operations
Jared M. Freedberg
General Counsel
M. Michelle Berrey
President, Research & Development & CMO
Valerie Keller
Executive Administrator To Chief Human Resources Officer
Victoria Carey
Senior Vice President, US Commercial
Ciso Alexandra Zafra Cissp, Cipp, Fip
Chief Information Security Officer, Hipaa Security Officer
Dick Lancaster
Vice President, Product Development
Paul Nitschmann
SVP Regulatory Affairs
Nathan Lai
Director, SOX And Internal Audit Compliance
Jonathan Miles
Corporate Counsel
Deryk David
Senior Vice President
Islah Ahmed
Vice President Medical Safety & Pharmacovigilance
Leona Bessonova Ph.D.
Executive Director, Head Of Medical Research
Belen Vendrell
Regional Medical Director
Darren Wheeler
Senior Medical Director
Kryzhanovskaya Ludmila
Executive Medical Director
Leighland Feinman
Medical Director
Carolin Bevis
Sr. Manager, Global Medical Affairs Operations
Xiaomei Jin
Principal Clinical Research Scientist
Amarita S Randhawa Pharmd
Executive Medical Director - Nash, Medical Affairs
Pharm. D. Nikeshia Dunkelly-Allen
Associate Medical Director US Medical Affairs
Julienne Apacible
Associate Director
Shivam Patel Pharmd, Rph, Mbac
Senior Manager, US Medical Affairs
Mustafa Kamal Pharmd
Medical Science Liaison (northeast)
Theo Altheide
Associate, Operations And Planning, Medical Affairs
Hernan Cortez
Head, U.s. Key Accounts, Gastroenterology And Hepatology
Daniel Bajek
Director, Financial Reporting
Doug Houser
Director, Strategic Accounts
Julia Pronina
Director, Financial Planning & Analysis
Sara Whipple
Executive Director - Financial Planning & Analysis
Thomas Rosenberg
Director Accounting - Assistant Controller